Challenges of Managing Adult Acute Lymphoblastic Leukaemia in 2025
Tracks
-
| Monday, April 28, 2025 |
| 8:00 AM - 9:30 AM |
| M4 |
Details
This educational session will focus on some specific challenges in managing adult ALL in 2025 including the use of Blinatumomab in first response, an update on the upcoming UKALL 15 trial and challenges in monitoring and managing patients with Ph+ ALL. There will also be a talk on real world data for the use of CAR-T in adult ALL including data from the UK national CAR-T panel
Speaker
Dr Clare Rowntree
Consultant Haematologist
University Hospital of Wales
Blinatumomab in NHS practice in 2025
8:00 AM - 8:20 AM
Prof. Adele Fielding
Professor Of Haematology
University of York
Update on plans for UKALL 15 - the next UK frontline study in adult ALL
8:20 AM - 8:40 AM
Dr. Gillian Horne
Senior Clinical Research Fellow and Honorary
University of Glasgow
The changing landscape of Ph+ ALL
8:40 AM - 9:00 AM
Dr Deborah Yallop
Consultant Haematologist
King’s College Hospital NHS Foundation Trust
CAR-T in adult ALL – update from the national CAR-T panel
9:00 AM - 9:30 AMChair
Clare Rowntree
Consultant Haematologist
University Hospital of Wales
